title: Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema.
authors: Reinhard
authors: R
authors: Bos
authors: Esther G M
authors: EG
authors: de Waal
authors: Hilde
authors: H
authors: Kuiper
authors: Bouke P C
authors: BP
authors: Hazenberg
authors: Edo
authors: E
authors: Vellenga
mesh_terms: D001943:Breast Neoplasms / Q000150:complications / Q000473:pathology / Q000628:therapy; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000150:complications / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008875:Middle Aged; D012074:Remission Induction; D053718:Scleromyxedema / Q000150:complications / Q000473:pathology / Q000628:therapy*; D012867:Skin / Q000473:pathology; D033581:Stem Cell Transplantation; D013792:Thalidomide / Q000627:therapeutic use*; D014182:Transplantation, Autologous; D016896:Treatment Outcome
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D013792:Thalidomide; D003907:Dexamethasone